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represent any agency determination or policy.
Basis for concern about health and 
safety effects of nanoparticles
 Findings from air pollution epidemiology
 Particles < 2.5 µm associated with respiratory and 
cardiovascular effects
 Studies of industrial fumes (e.g., welding fumes) 
and combustion (e.g., diesel) products
 Wide range of effects: pulmonary and eye irritation, 
fever, lung cancer
 Initial animal inhalation studies of engineered 
nanomaterials
 Pulmonary fibrosis, granulomas, and inflammation
 Lung cancer, mesothelioma-like effects
 Cardiovascular effects: oxidative stress, plaque
Why the workplace?
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 Early in the history of a material
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Major knowledge gaps related to 
nanotechnology health and safety
Risk Management
Develop procedures to minimize exposures
Risk Characterization
Is substance hazardous and will there be exposure?
Exposure Assessment
Will there be exposure in real-world conditions?
Hazard Identification
Is there reason to believe this could be harmful?
Approaches to Safe Nanotechnology (DHHS (NIOSH) Publication 2009-125)
Hazard Identification
“Is there reason to believe this 
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Risk Management
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Nanotoxicology
What do we know?
Are there “trends?”
Key elements 
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Nanotoxicology: key findings
Pulmonary exposure to:
Carbon nanotubes causes 
rapid and persistent fibrosis in 
mice
Certain nanoparticles
(SWCNT or TiO2 ) can cause 
cardiovascular dysfunction
MWCNT or TiO2 nanowires
can induce inflammatory 
mediators in certain regions 
of the brain
Courtesy of 
R. Mercer, NIOSH
Nanotoxicology: key findings
Carbon nanotubes
Multi-walled 
nanotubes can reach 
the intrapleural space 
(site of mesotheliomia)
Single-walled 
nanotubes can 
interfere with cell 
divisionCourtesy of 
R. Mercer, NIOSH
What could a “nanoparticle” be?
Dr. A . Maynard: Woodrow Wilson International Center for Scholars
Same composition—different shape
Zinc oxide nanoparticles
Materials Today June 2004. Zhong Lin Wang, Georgia Institute of  Technology  
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Can it be measured?
Where is it occurring?
Metric?
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Diverse exposure scenarios evaluated
Weighing MWCNT’s 
PBZ sample collected on a 
polycarbonate filter and 
analyzed by SEM 
Evidence of exposure
Harvesting SWCNT’s, scraping product from 
wall of Carbon Arc Reactor
Task-based “At source” air sample
Evidence of exposure
Examples of NIOSH field investigations
Type of Facility Type of Particle, 
Morphology
Size of Particle Range of “Potential” 
Exposure Concentrations
University Research lab Carbon Nanofibers Approx. 100 nm 
diameter, 1–10 
microns long
60-90 µg/m3  Total Carbon
Metal Oxide Manufacturer TiO2, Lithium Titanate, 
powder
100–200 nm <100 nm: 1.4 µg/m3 (TiO2)
Total dust: 4-149 µg/m3 (TiO2)
<100 nm: ND (Li)
Total dust: ND -3 µg/m3 (Li)
Manufacturer Carbon Nanofibers Approx. 100 nm 
diameter, 1–10 
microns long
15 - 1800 µg/m3  Total carbon
Research and 
Development lab
Quantum Dots, spheres 2–8 nm ND
Metal Oxide Manufacturer Manganese, Silver, Nickel, 
Cobalt, Iron oxides, 
spheres
8–50 nm 67 - 3619 µg/m3   
Mg, Ag, Ni, Co, Fe
Research and 
Development lab (Pilot-
Scale)
Aluminum, spheres 50–100 nm 40 - 276 µg/m3  Al
Research and 
Development lab
Elemental metals: Silver, 
copper, TiO2
15–40 nm ND
Filter Media Manufacturer Nylon 6 Nanofiber 70–300 nm 
diameter, 
continuous length
ND
Nanoparticle Emission Assessment Technique 
(NEAT) for the Identification and Measurement 
of Potential Inhalation Exposure to Engineered 
Nanomaterials — Part A
and
Part B: Results from 12 Field Studies
M. Methner, L. Hodson, C. Geraci 
National Institute for Occupational Safety and 
Health (NIOSH), Nanotechnology Research 
Center, Cincinnati, Ohio
Recent published summary of field exposure assessments
Journal of Occupational and 
Environmental Hygiene March 2010
Collaboration
 Share knowledge
 Use expertise
 Build experience
 Partner
The NIOSH Nanotechnology field team 
is available for field assessments.   
Contact us.
Hazard Identification
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world conditions?” 
Risk Characterization
“Is substance hazardous and will 
there be exposure?” 
Risk
Hazard x Exposure
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Quantitative Risk Assessment in developing 
Recommended Exposure Limits for nanoparticles
Assume equal response to equivalent dose
Rat
Dose-response model  
(particle surface area dose 
in lungs)
Calculate tissue dose --
BMD
Extrapolate
Working lifetime 
exposure concentration*
Equivalent tissue dose
Human lung 
dosimetry model
Recommended 
exposure limit
Technical feasibility 
Variability/uncertainty
(species differences 
in lung mass or 
surface area)
*Compare rat-based risk estimates with confidence intervals from human studies 
Human
Risk Assessment: ultrafine (nano) TiO2
 NIOSH draft recommended exposure limits 
(RELs)
 1.5 mg/m3 fine TiO2
 0.1 mg/m3 ultrafine TiO2
 Reflects greater inflammation & tumor risk of 
ultrafine on mass basis
 This recommendation will be released from 
NIOSH in the Autumn of 2010
 Key message: The OEL for a material in its 
“large” form may not be appropriate for the nano
form.
Hazard and risk picture: carbon nanotubes
 SWCNTs more fibrogenic then an equal mass of 
ultrafine carbon black or fine quartz
 Doses approximated exposure at the PEL for 
graphite (5 mg/m3) for 20 days
 MWCNT can penetrate the pleura
 More data needed
 Similar message: The OEL for the “large” form of a 
material may not be a good guide for the nano form.
Key NIOSH project: Current Intelligence Bulletin on 
Carbon Nanotubes
Key responses: Industry OELs
Hazard Identification
“Is there reason to believe this 
could be harmful?” 
Risk Management
“Develop procedures to minimize 
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world conditions?” 
Risk Characterization
“Is substance hazardous and will 
there be exposure?” 
Recognize and
Manage Risk
What works?
What has been used?
What can be reapplied?
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Conventional controls should work
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Filtration performance of an example NIOSH 
approved N95 filtering facepiece respirator
n=5; Error bars represent standard deviations
TSI 3160; Flow rate 85 L/min
Basic Guidance from NIOSH
Updated and re-issued in 2009
Based on direct experience and 
applied research results
Updated as new information is 
developed
A starting point for building a 
responsible nanomaterial 
management program
www.cdc.gov/niosh/topics/nanotech
Interim guidance issued by NIOSH
Value of medical screening
Lack of specific health end point
Hazard Surveillance
Potential for Exposure Registry
http://www.cdc.gov/niosh/topics/nanotech/keystone2010/default.html
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Estimated number of workers actually
exposed to engineered nanoparticles
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Dilemmas in identifying workers exposed to 
engineered nanoparticles
Feynman’s 
vision
Beginning of  
commercialization
Schulte, 2009
Global employment est.
USA employment est. (Roco
& Bainbridge, 2005)
Exposure registries
 Used in public health for over 50 years
 May serve as a societal response to 
hazardous exposures
 May serve as preparatory step for 
epidemiological studies
Questions about exposure registries
 Who would manage them?
 What data would be collected?
 Who would have access to the data?
 Could any investigator with a research proposal 
have access to the registry?
 Are there non-research implications and 
responsibilities for those who manage registries?
 Are there expectations for those who participate in 
them?
Thank you!
Pschulte@cdc.hhs.gov
